Table 1.
Univariate and multivariate cox analysis of CACNA1C and clinicopathologic characteristics of overall survival in TCGA OV cohort
| Clinical characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95 % CI) | p-Value | HR (95 % CI) | p-Value | |
| Stage | 1.301(0.954–1.775) | 0.097 | 1.359(0.984–1.878) | 0.063 |
| Grade | 1.073(0.758–1.519) | 0.690 | 0.969(0.671–1.401) | 0.869 |
| Age | 1.316(0.964–1.797) | 0.084 | 1.283(0.931–1.770) | 0.128 |
| Location | 1.062(0.839–1.344) | 0.618 | 1.056(0.829–1.344) | 0.660 |
| Race | 0.798(0.543–1.173) | 0.250 | 0.772(0.524–1.137) | 0.190 |
| Status | 0.981(0.707–1.360) | 0.906 | 1.076(0.768–1.507) | 0.671 |
| Diagnosis | 0.896(0.707–1.136) | 0.365 | 0.918(0.717–1.174) | 0.493 |
| Venous_invasion | 0.903(0.731–1.114) | 0.341 | 0.928(0.744–1.157) | 0.506 |
| Chemotherapy | 0.683(0.402–1.616) | 0.159 | 0.649(0.374–1.127) | 0.124 |
| Outcome | 0.997(0.912–1.089) | 0.941 | 1.020(0.929–1.120) | 0.673 |
| CACNA1C | 1.611(1.263–2.054) | < 0.001 | 1.615(1.261–2.067) | < 0.001 |